Skip to content

Treatment of lateral knee joint pain with artificial lateral meniscus prosthesis after meniscectomy.

Treatment of lateral knee joint pain with artificial lateral meniscus prosthesis after meniscectomy. - Early ARtificial laTeral prostHesis (EARTH)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57018
Enrollment
16
Registered
2023-10-26
Start date
2024-11-21
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post meniscectomy pain pain after meniscectomy

Interventions

Implantation with the lateral meniscus prosthesis (LMP) system.

Sponsors

ATRO Medical B.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Is aged 18 to 70 years (inclusive) at the time of screening 2. Has a history of partial or total meniscectomy 3. Has post-meniscectomy pain syndrome (defined as symptomatic unicompartmental  pain in the meniscus- deficient knee without severe cartilage damage- Kellgren  & Lawrence grade 3-4) in the lateral compartment as confirmed by patient  history and MRI 4. Has a KOOS Pain of <= 75 at the time of screening 5. Failed conservative treatment options (non-operative treatments of the knee,  i.e., self-management exercise programs, physical therapy, braces, pain  medication, and intra-articular corticosteroids) 6. Has neutral alignment of the mechanical axis: valgus less than 5°  7. Is willing to be implanted with the LMP System and to comply with  instruction for use 8. Is able and willing to do the study required follow-up visits,  questionnaires, X-rays, and MRI 9. Is able and willing to understand and sign the study Informed Consent Form 10. Is able to read and understand the national language of the country in  which the clinical site is located.

Exclusion criteria

Exclusion criteria: 1. Has severe knee osteoarthritis; Kellgren & Lawrence grade 4 in the  lateral compartment 2. Has evidence of a modified Outerbridge Grade IV cartilage loss on the  lateral tibial plateau or femoral condyle that potentially could contact the  meniscus prosthesis > 2cm2 3. Has medial compartment pain Grade IV modified Outerbridge  cartilage score > 2cm2 4. Has valgus knee alignment > 5° 5. Has a valgus alignment that is not passively correctable 6. Has a laxity level of more than Grade II (IKDC), primary or secondary to an  injury of the anterior cruciate ligament (ACL) and/or posterior cruciate  ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial  collateral ligament (MCL). 7. Has significant trochlear dysplasia, patellar instability or symptomatic  patellar misalignment 8. Has patellar compartment pain and Grade III or Grade IV modified Outerbridge  cartilage score in the patellar compartment 9. Had an ACL reconstruction performed < 9 months prior to surgery 10. Has a BMI > 35 at the time of screening 11. Received any type of prosthetic knee implant made of artificial  non-resorbable plastic, metal or ceramic, not including the lateral meniscus  prosthesis 12. Has a knee flexion contracture > 10° 13. Has flexion < 90° 14. Had a knee alignment correction osteotomy < 9 months ago 15. Has insufficiency fractures or avascular necrosis of the lateral  compartment

Design outcomes

Primary

MeasureTime frame
• Safety assessed by device related (S)AEs within 12 months of surgery. • Knee MRI (non-weight-bearing) at 12 months (extrusion measurement as measure for prosthesis integrity).

Secondary

MeasureTime frame
• The nature and frequency of all adverse events observed during the study including their timing, severity, and relatedness to the investigational device. • Incidence of secondary surgical intervention of the index knee. • Knee MRI (non-weight-bearing) at 12 months or explantation (extrusion measurement as measure for prosthesis and joint integrity including cartilage status).

Countries

Netherlands

Contacts

Public ContactT Struik

ATRO Medical B.V.

info@atromedical.com+31247009853

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026